pipeline

ICT-121

ICT-121 specifically targets CD133, a cancer stem cell marker that is overexpressed in a wide variety of solid tumors, including ovarian, pancreatic, and breast cancers. A 20-patient open-label, multi-center study was completed.

 

 

 

 

Copyright 2017 by Immunocellular Therapeutics, Ltd.
All Rights Reserved